Chronic Graft-Versus-Host Disease
Also known as: CGVHD / Chronic GVHD / Chronic Graft vs. Host Disease / Chronic graft versus host disease / Chronic graft-versus-host disease (disorder) / Chronic GVH disease
Drug | Drug Name | Drug Description |
---|---|---|
DB16703 | Belumosudil | An oral inhibitor of rho-associated coiled-coil-containing protein kinases (ROCK) used in the treatment of chronic graft-versus-host disease (GVHD). |
DB09053 | Ibrutinib | An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. |
DB08877 | Ruxolitinib | A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment. |
DB01041 | Thalidomide | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. |